Z4P is a BBB-penetrable IRE1 inhibitor with an IC 50 of 1.13 μM. Z4P in combination with Temozolomide ( HY-17364 ) inhibits the growth and recurrence of glioblastoma and has anti-tumor activity.
Products | Products > Disease Areas > Cancer | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > IRE1
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。